T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$1.66B |
| 2 |
Canadian Natural Resources
CNQ
|
+$759M |
| 3 |
Becton Dickinson
BDX
|
+$735M |
| 4 |
Ashland
ASH
|
+$669M |
| 5 |
Keysight
KEYS
|
+$573M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RTX Corp
RTX
|
+$1.73B |
| 2 |
Ecolab
ECL
|
+$1.17B |
| 3 |
Crown Castle
CCI
|
+$906M |
| 4 |
Phillips 66
PSX
|
+$775M |
| 5 |
Gilead Sciences
GILD
|
+$756M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.84% |
| 2 | Consumer Discretionary | 13.93% |
| 3 | Financials | 13.41% |
| 4 | Industrials | 12.4% |
| 5 | Technology | 9.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Zurn Elkay Water Solutions
ZWS
$8.51B
| $504M | 0.11% |
37,106,949
+2,760,048
| +8% | +$36.5M |
|
227
Marriott International
MAR
$92.4B
| $499M | 0.11% |
6,388,597
-1,320,314
| -17% | -$97.5M |
|
228
Xcel Energy
XEL
$48.9B
| $495M | 0.11% |
13,788,150
-18,724,605
| -58% | -$629M |
|
229
Xerox
XRX
$414M
| $491M | 0.1% |
13,443,556
-70,254
| -0.5% | -$2.48M |
|
230
General Motors
GM
$77.2B
| $489M | 0.1% |
14,018,938
-78,480
| -0.6% | -$2.51M |
|
231
Nucor
NUE
$61.6B
| $487M | 0.1% |
9,930,214
+47,112
| +0.5% | +$2.45M |
|
|
FEIC
232
DELISTED
FEI COMPANY
FEIC
| $485M | 0.1% |
5,369,503
+113,300
| +2% | +$9.45M |
|
233
Willis Towers Watson
WTW
$31.4B
| $485M | 0.1% |
4,083,267
+1,777,790
| +77% | +$199M |
|
|
VMW
234
DELISTED
VMware, Inc
VMW
| $483M | 0.1% |
5,857,718
+1,418,069
| +32% | +$121M |
|
235
Micron Technology
MU
$1.03T
| $483M | 0.1% |
13,799,455
+1,808,761
| +15% | +$59.9M |
|
236
Corning
GLW
$143B
| $483M | 0.1% |
21,043,940
-1,527
| -0% | -$31.1K |
|
|
K
237
DELISTED
Kellanova
K
| $481M | 0.1% |
7,820,948
+4,016,513
| +106% | +$241M |
|
238
RPM International
RPM
$14.7B
| $480M | 0.1% |
9,468,057
+2,779,845
| +42% | +$129M |
|
239
McDonald's
MCD
$193B
| $479M | 0.1% |
5,115,626
+2,437,254
| +91% | +$228M |
|
240
Choice Hotels
CHH
$4.68B
| $478M | 0.1% |
8,529,293
+58,150
| +0.7% | +$3.12M |
|
241
Stanley Black & Decker
SWK
$15.4B
| $477M | 0.1% |
4,965,045
-66,831
| -1% | -$6.16M |
|
242
Sprouts Farmers Market
SFM
$7.82B
| $471M | 0.1% |
13,873,969
+3,754,828
| +37% | +$115M |
|
243
Clorox
CLX
$12.8B
| $464M | 0.1% |
4,453,730
-657,670
| -13% | -$65.8M |
|
244
Capri Holdings
CPRI
$1.72B
| $464M | 0.1% |
6,172,655
-5,125,279
| -45% | -$382M |
|
245
L3Harris
LHX
$53B
| $462M | 0.1% |
6,432,070
+9,910
| +0.2% | +$685K |
|
246
Macy's
M
$6.3B
| $460M | 0.1% |
6,995,162
-155,099
| -2% | -$9.38M |
|
247
SS&C Technologies
SSNC
$18.5B
| $459M | 0.1% |
15,711,436
-476,720
| -3% | -$11.8M |
|
|
MWV
248
DELISTED
MEADWESTVACO CORP
MWV
| $459M | 0.1% |
10,332,026
-294,560
| -3% | -$12.8M |
|
|
CVC
249
DELISTED
CABLEVISION SYS CP NY GRP CL-A
CVC
| $457M | 0.1% |
22,145,835
+747,765
| +3% | +$14.3M |
|
250
Southwest Airlines
LUV
$22B
| $452M | 0.1% |
10,689,423
-4,784,542
| -31% | -$179M |
|
Similar funds
T. Rowe Price Associates's Q4 2014 Portfolio in Review
As of Q4 2014, T. Rowe Price Associates held 2,627 positions worth $471B, up 2.8% from $458B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
T. Rowe Price Associates's Q4 2014 filing shows 87 new, 929 increased, 999 reduced and 89 closed positions. Its largest new stake was Keysight: 17,553,953 shares worth $593M. The largest sale was RTX Corp, an estimated $1.73B.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q4 2014 buy was Keysight: 17,553,953 shares worth $593M.
- T. Rowe Price Associates added most to Allergan plc in Q4 2014, an estimated $1.66B increase.
- T. Rowe Price Associates's biggest Q4 2014 reduction was RTX Corp, cutting an estimated $1.73B.
- T. Rowe Price Associates fully exited ATHLON ENERGY INC COM in Q4 2014, selling an estimated $499M.
- T. Rowe Price Associates's ten largest holdings make up 13% of its $471B portfolio in Q4 2014.
- T. Rowe Price Associates opened 87 new positions and closed 89 in Q4 2014.
- T. Rowe Price Associates's portfolio value rose 2.8% quarter-over-quarter to $471B.
Based on T. Rowe Price Associates's 13F filing for Q4 2014, filed 13 Feb 2015.